A human in vitro platform for the evaluation of pharmacology strategies in cardiac ischemia

Cardiac ischemic events increase the risk for arrhythmia, heart attack, heart failure, and death and are the leading mortality condition globally. Reperfusion therapy is the first line of treatment for this condition, and although it significantly reduces mortality, cardiac ischemia remains a signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Oleaga, Carlota, Jalilvand, Golareh, Legters, Gregg, Martin, Candace, Ekman, Gail, McAleer, Christopher W., Long, Christopher J., Hickman, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIP Publishing LLC 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692160/
https://www.ncbi.nlm.nih.gov/pubmed/31431939
http://dx.doi.org/10.1063/1.5089237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692160/
https://www.ncbi.nlm.nih.gov/pubmed/31431939
http://dx.doi.org/10.1063/1.5089237

Ejemplares similares